IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Over the last 12 months, insiders at IN8bio, Inc. have bought $28,395 and sold $0 worth of IN8bio, Inc. stock.
On average, over the past 5 years, insiders at IN8bio, Inc. have bought $1.44M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ho William Tai-Wei (President and CEO) — $24,990. Graff Jeremy R. (director) — $2,375. McCall Patrick (Chief Financial Officer) — $1,030.
The last purchase of 2,500 shares for transaction amount of $2,375 was made by Graff Jeremy R. (director) on 2023‑09‑13.
2023-09-13 | Graff Jeremy R. | director | 2,500 0.0077% | $0.95 | $2,375 | +14.24% | ||
2023-08-25 | McCall Patrick | Chief Financial Officer | 1,000 0.0032% | $1.03 | $1,030 | +2.91% | ||
2023-08-24 | Ho William Tai-Wei | President and CEO | 23,800 0.0719% | $1.05 | $24,990 | +3.92% | ||
2022-12-12 | Kreis Leslie W. | director | 75,001 0.359% | $2.48 | $185,912 | -44.94% | ||
2022-12-12 | Fletcher Aaron G.L. | director | 75,001 0.359% | $2.48 | $185,912 | -44.94% | ||
2022-09-28 | Kreis Leslie W. | 25,000 0.1111% | $2.02 | $50,535 | -18.57% | |||
2022-09-28 | Fletcher Aaron G.L. | 25,000 0.1111% | $2.02 | $50,535 | -18.57% | |||
2022-08-26 | Cavu Advisors, LLC | 31,805 0.1513% | $2.02 | $64,232 | -5.10% | |||
2022-08-17 | Cavu Advisors, LLC | 38,035 0.1712% | $1.93 | $73,408 | -5.30% | |||
2022-08-17 | BIOS Advisors GP, LLC | 38,035 0.1712% | $1.93 | $73,408 | -5.30% | |||
2022-08-16 | Transcend Partners Opportunity Fund LLC | 789,473 3.713% | $1.90 | $1.5M | +1.07% | |||
2022-08-16 | Ho William Tai-Wei | President, CEO and CFO | 26,315 0.1238% | $1.90 | $49,999 | +1.07% | ||
2022-08-16 | Cavu Advisors, LLC | 206,575 0.9715% | $1.90 | $392,493 | +1.07% | |||
2022-08-16 | BIOS Advisors GP, LLC | 206,575 0.9715% | $1.90 | $392,493 | +1.07% | |||
2022-08-16 | Brandt Peter C. | 105,263 0.4951% | $1.90 | $200,000 | +1.07% | |||
2022-08-16 | Lamb Lawrence | EVP and CSO | 526 0.0025% | $1.90 | $999 | +1.07% | ||
2022-08-16 | Roemer Alan S. | 26,315 0.1238% | $1.90 | $49,999 | +1.07% | |||
2022-08-16 | Greenwood Luba | 526 0.0025% | $1.90 | $999 | +1.07% | |||
2022-08-16 | Rochlin Kate | Chief Operating Officer | 5,263 0.0248% | $1.90 | $10,000 | +1.07% | ||
2022-08-16 | McCall Patrick | Chief Financial Officer | 5,263 0.0248% | $1.90 | $10,000 | +1.07% |
Ho William Tai-Wei | President and CEO | 2339545 5.4047% | $0.88 | 2 | 0 | +1.07% |
McCall Patrick | Chief Financial Officer | 6263 0.0145% | $0.88 | 2 | 0 | +1.07% |
Graff Jeremy R. | director | 2500 0.0058% | $0.88 | 1 | 0 | |
Transcend Partners Opportunity Fund LLC | 4111958 9.4992% | $0.88 | 1 | 0 | +1.07% | |
Kreis Leslie W. | director | 3727597 8.6113% | $0.88 | 2 | 0 | <0.0001% |
Fletcher Aaron G.L. | director | 3727597 8.6113% | $0.88 | 2 | 0 | <0.0001% |
Cavu Advisors, LLC | 3651528 8.4356% | $0.88 | 3 | 0 | <0.0001% | |
BIOS Advisors GP, LLC | 3612569 8.3456% | $0.88 | 2 | 0 | <0.0001% | |
FAIRBAIRN EMILY | 3322485 7.6754% | $0.88 | 1 | 0 | <0.0001% | |
Brandt Peter C. | 182473 0.4215% | $0.88 | 1 | 0 | +1.07% | |
Lamb Lawrence | EVP and CSO | 99730 0.2304% | $0.88 | 1 | 0 | +1.07% |
Roemer Alan S. | 55989 0.1293% | $0.88 | 1 | 0 | +1.07% | |
Greenwood Luba | 7826 0.0181% | $0.88 | 1 | 0 | +1.07% | |
Rochlin Kate | Chief Operating Officer | 5263 0.0122% | $0.88 | 1 | 0 | +1.07% |
Goswami Trishna | Chief Medical Officer | 2631 0.0061% | $0.88 | 1 | 0 | +1.07% |
Aigh Capital Management Llc | $3.39M | 6.52 | 2.87M | -29.85% | -$1.44M | 2.01 | |
The Vanguard Group | $1.68M | 3.23 | 1.42M | +241.71% | +$1.19M | <0.0001 | |
Ensign Peak Advisors Inc | $1.32M | 2.53 | 1.12M | 0% | +$0 | <0.01 | |
683 Capital Management Llc | $725,410.00 | 1.39 | 614,754 | 0% | +$0 | 0.08 | |
Sigma Planning Corp | $607,794.00 | 1.17 | 515,080 | +289.53% | +$451,762.70 | 0.02 | |
Alyeska Investment Group L P | $526,299.00 | 1.01 | 446,016 | -45.59% | -$440,914.18 | <0.01 | |
Voss Capital LLC | $381,705.00 | 0.73 | 323,479 | -5.2% | -$20,921.39 | 0.03 | |
Geode Capital Management | $331,106.00 | 0.64 | 280,544 | +40.68% | +$95,748.39 | <0.0001 | |
Stonegate Investment Group Llc | $212,400.00 | 0.41 | 180,000 | 0% | +$0 | 0.01 | |
Rock Creek Group Lp | $208,813.00 | 0.34 | 151,314 | 0% | +$0 | <0.0001 | |
Renaissance Technologies | $141,000.00 | 0.27 | 119,155 | +508.62% | +$117,832.71 | <0.0001 | |
Bridgeway Capital Management | $121,896.00 | 0.23 | 103,302 | +31.93% | +$29,499.91 | <0.01 | |
Texas Capital Bank Wealth Management Services Inc | $92,776.00 | 0.18 | 78,624 | 0% | +$0 | 0.01 | |
State Street | $69,910.00 | 0.13 | 59,246 | 0% | +$0 | <0.0001 | |
Northern Trust | $57,845.00 | 0.11 | 49,021 | 0% | +$0 | <0.0001 | |
Laird Norton Trust Company Llc | $49,914.00 | 0.1 | 42,300 | 0% | +$0 | 0.01 | |
Two Sigma | $49,003.00 | 0.09 | 41,528 | -1.89% | -$941.64 | <0.0001 | |
Overbrook Management Corp | $39,832.00 | 0.08 | 33,756 | 0% | +$0 | 0.01 | |
Millennium Management LLC | $38,417.00 | 0.07 | 32,557 | New | +$38,417.00 | <0.0001 | |
BlackRock | $33,281.00 | 0.06 | 28,204 | -2.15% | -$731.61 | <0.0001 | |
Wela Strategies Inc | $21,887.00 | 0.04 | 18,548 | New | +$21,887.00 | 0.01 | |
TWO SIGMA SECURITIES LLC | $20,717.00 | 0.04 | 17,557 | New | +$20,717.00 | <0.0001 | |
Ground Swell Capital Llc | $19,300.00 | 0.04 | 16,356 | New | +$19,300.00 | 0.02 | |
Virtu Financial Llc | $17,000.00 | 0.03 | 14,044 | New | +$17,000.00 | <0.01 | |
Charles Schwab | $15,464.00 | 0.03 | 13,105 | 0% | +$0 | <0.0001 | |
Westside Investment Management Inc | $14,160.00 | 0.03 | 12,000 | -17.24% | -$2,950.00 | <0.01 | |
Goldman Sachs | $13,702.00 | 0.03 | 11,612 | New | +$13,702.00 | <0.0001 | |
Tower Research Capital | $12,851.00 | 0.03 | 10,891 | +78.89% | +$5,667.37 | <0.0001 | |
Vontobel Holding Ltd | $11,800.00 | 0.02 | 10,000 | 0% | +$0 | <0.0001 | |
Wells Fargo | $291.00 | <0.01 | 247 | +56.33% | +$104.85 | <0.0001 | |
JPMorgan Chase | $81.00 | <0.01 | 69 | +102.94% | +$41.09 | <0.0001 | |
Royal Bank of Canada | $0 | <0.01 | 47 | -82.2% | -$0 | <0.0001 |